Investor Day 2025
Logotype for CVS Health Corporation

CVS Health (CVS) Investor Day 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for CVS Health Corporation

Investor Day 2025 summary

3 Feb, 2026

Strategic vision and business transformation

  • Committed to becoming America's most trusted healthcare company by simplifying care, improving access, affordability, and outcomes for 185 million people served, and transitioning to a consumer-focused health solutions business leveraging technology and digital solutions.

  • Executed a major leadership overhaul, exited non-core businesses, and invested $20 billion over 10 years in technology to enable growth and integration across business lines.

  • Established four growth pillars: best-in-class execution in core businesses, transforming consumer experiences, partnering with providers, and leveraging enterprise capabilities through technology.

  • Announced the launch of an Open Consumer Engagement Platform, aiming to commercialize technology assets and offer 'Engagement as a Service' to the industry by 2026, with active partner discussions.

  • Emphasized the unique reach of 9,000+ locations, 300,000 colleagues, and 85% of the U.S. population living within 10 miles of a facility.

Financial guidance and performance outlook

  • Raised 2025 guidance to at least $400 billion in revenue and $6.60–$6.70 adjusted EPS, with 2026 guidance of at least $400 billion in revenue and $7.00–$7.20 adjusted EPS.

  • Projects mid-teens adjusted EPS CAGR through 2028, driven by diversified businesses, Aetna margin recovery, specialty pharmacy growth, and improved healthcare delivery performance.

  • 2026 adjusted operating income projected at $15.07–$15.41 billion, with all business segments contributing to growth.

  • Strong cash flow generation expected, with $55–$60 billion deployable cash from 2026 to 2028, prioritizing deleveraging, dividends, and future share repurchases.

  • Investments for the Open Engagement Platform are included in guidance, but upside from its commercialization is not yet reflected in long-term projections.

Business segment highlights and innovations

  • Aetna/Health Care Benefits achieved $2.5 billion AOI improvement in 2025, with further $1.7 billion targeted for 2026, focusing on operational excellence, technology, and new care models, and renewed focus on Medicare Advantage and Medicaid.

  • Healthcare delivery pivoted Oak Street Health from rapid expansion to margin improvement, expanded MinuteClinic primary care to 400+ locations, and enhanced Signify Health offerings.

  • Caremark retained 98% of customers, won $6 billion in new business, led in transparent pricing with TrueCost, and delivered $1.5 billion in client and member savings through biosimilars.

  • Specialty pharmacy remains the largest in the U.S., serving 2.2 million patients, leveraging AI and automation to reduce therapy start times by 45%.

  • Retail pharmacy reset earnings trajectory to at least flat, driven by cost discipline, technology, omnichannel expansion, and market share gains.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more